SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved down -39.28% to Rs. 128.60 millions for the September 2024 quarter as compared to Rs. 211.80 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2024 is Rs. -1076.90 millions as compared to Net Loss of Rs. -864.20 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 further decreased to -1038.10% as compared to -829.80% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 128.60 211.80 -39.28 296.70 451.30 -34.26 755.50 2387.80 -68.36
Other Income 0.40 84.90 -99.53 16.00 186.80 -91.43 294.70 108.80 170.86
PBIDT -1038.10 -829.80 25.10 -1973.70 -1749.70 12.80 -3743.20 -2031.80 84.23
Interest 11.10 2.60 326.92 16.30 5.20 213.46 16.60 76.30 -78.24
PBDT -1049.20 -832.40 26.05 -1990.00 -1754.90 13.40 -3759.80 -2108.10 78.35
Depreciation 27.70 31.80 -12.89 55.30 62.80 -11.94 121.30 117.70 3.06
PBT -1076.90 -864.20 24.61 -2045.30 -1817.70 12.52 -3881.10 -2225.80 74.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1076.90 -864.20 24.61 -2045.30 -1817.70 12.52 -3881.10 -2225.80 74.37
Equity 324.50 324.50 0.00 324.50 324.50 0.00 324.50 324.50 0.00
PBIDTM(%) -807.23 -391.78 106.04 -665.22 -387.70 71.58 -495.46 -85.09 482.27

Sun Pharma Adv. Res Share Price

147.90 -4.25 (-2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×